RI Hospital among top 50 cardiovascular programs
Rhode Island Hospital is among the nation’s top cardiovascular programs, according to IBM Watson Health’s recent “50 Top Cardiovascular Hospitals 2018” study. Rhode Island Hospital is one of only three hospitals in New England to earn the distinction, and the only one in the state.
The annual study, conducted by IBM Watson Health’s Truven Health Analytics, identifies the top U.S. hospitals for inpatient cardiovascular services. The study uses a balanced national scorecard of hospital performance metrics to identify the highest performing cardiovascular service lines in the nation.
This study is part of the Watson Health 100 Top Hospitals program. All these studies use rigorous processes to calculate and measure hospital service lines, leveraging industry-leading, risk-adjusted methodologies developed and maintained by IBM Watson Health scientists over many years. The 100 Top Hospitals study is widely regarded as a leading program for evaluating leadership impact in a hospital, as well as for evaluating quality indicators and efficiencies.
The Watson Health 50 Top Cardiovascular Hospitals study measures attainment in key performance areas: risk-adjusted inpatient mortality, risk-adjusted complications, percentage of coronary bypass patients with internal mammary artery use, 30-day mortality rates, 30-day readmission rates, severity-adjusted average length of stay, wage- and severity-adjusted average cost per case and CMS 30-day episode payment measures. The study has been conducted annually since 1999. This is the fourth time Rhode Island Hospital has been recognized with this honor.
“We are so honored that Rhode Island Hospital has been recognized by IBM Watson for our cardiac care. This speaks volumes to the tremendous expertise within the Lifespan Cardiovascular Institute, and the outstanding patient care provided in the inpatient setting at Rhode Island Hospital,” said Margaret M. Van Bree, M.H.A., Dr.P.H., president of Rhode Island Hospital.
The top hospitals were announced in the Nov. 6, 2017, edition of Modern Healthcare magazine.